Halberd Corporation Continues Seeking Government Contracts with Scientists at Mississippi State University

Core Insights - Halberd Corporation is collaborating with Mississippi State University to develop a nasal spray treatment for Traumatic Brain Injury (TBI) and is seeking government funding for advanced animal research [1][3]. Group 1: Product Development - The nasal spray treatment is designed for immediate use following head trauma, aiming to mitigate negative effects associated with TBI [2]. - The planned Phase-2 animal research will assess the efficacy of the nasal spray in reducing biochemical changes and behavioral deficits caused by TBI from various sources [3]. - Previous Phase-1 testing indicated that animals receiving the nasal spray showed reduced markers of TBI-induced damage compared to those that did not [3]. Group 2: Technological Integration - The Phase-2 tests will utilize Artificial Intelligence capabilities from Halberd's acquisition of NeuroSense AI to enhance research outcomes [4]. - NeuroSense AI aims to transform preclinical TBI research through multi-modal behavioral analysis and advanced AI interpretation [6]. Group 3: Market Potential - The nasal spray could provide significant advantages for the military by enabling expedited return-to-duty for personnel following head trauma or anxiety conditions [4]. - Halberd Corporation is also exploring private investment and potential corporate restructuring to support its initiatives [5].